Price (GBX)
56.50 2.73%
ODXORD 4P
Track 1 instrument
Open / Last close
- / 56.50
High / Low
56.50 / 50.50
Bid / Offer
56.00 / 57.00
Turnover
£1,050.00
Special Condition: -
Trading Status: Market Close
As at 05.08.20 06:12:07 - All data delayed at least 15 minutes

Omega Diagnostics Group PLC instruments

Select instrument to view
Equity (1)
Code Instrument name Price Change Type Documentation
ODXORD 4P56.50
GBX
2.73%Equity-

Price information

What's this?
Open price
-
Previous close price / date
56.50 / 04 August 2020
Volume
3,803,966
Turnover
£1,050.00
52 week range
6.75 / 73.50
YTD return
292.36
1 year return
494.74

Instrument information

What's this?
Instrument market cap (£m)
98.01
Earnings per share
0.01
Dividend (yield)
- %
Issue date
31 August 2007
ISIN
GB00B1VCP282
SEDOL
B1VCP28
Market identifier code (MIC)
AIMX
Country of share register
GB
Market segment
ASX1
Trading service
SETSqx
Date Time Price CurrencyVolume Trade ValueTrade type Trade flag MIC
04.08.20 16:02:59 54.80 GBX 29,900 16,385.20 Off-Book LRGS AIMX
04.08.20 15:42:53 54.55 GBX 30,000 16,365.00 Off-Book LRGS AIMX
04.08.20 16:27:35 56.00 GBX 15,000 8,400.00 Off-Book LRGS AIMX
04.08.20 16:24:55 56.50 GBX 19,453 10,990.95 Off-Book LRGS AIMX
04.08.20 16:21:28 54.55 GBX 13,379 7,298.24 Off-Book LRGS AIMX

Equity Research

from Omega Diagnostics Group PLC
Morning Note – 14 July 2020

Bango (BGO): Corp | DX (DX): Corp | Elecosoft (ELCO): Corp | IQGeo Group (IQG): Corp | Netcall (NET): Corp | Omega Diagnostics (ODX): Corp | Somero Enterprises (SOM): Corp

View report
FY 2020 results – multiple upcoming newsflow

Full-year results to 31 March were in line with the trading update at the time of the recent fundraise (£10.5m net), with revenues, adjusted pre-tax loss from the continuing businesses and year-end net debt of £9.8m (+12%), £0.4m and £0.8m, respectively. The company is ful ...

View report
SP Angel Healthcare Conditions

Creo Medical (CREO.L): Sterilisation tool against COVID-19 | Omega Diagnostics (ODX.L): Indian approval for COVID-19 antibody test

View report
Morning Note – 2 July 2020

Omega Diagnostics (ODX): Corp COVID-19 update – ELISA test approved in India

View report
Morning Note – 29 June 2020

KRM22 (KRM): Corp | Morses Club (MCL): Corp | Omega Diagnostics (ODX): Corp

View report

Latest reports

from Omega Diagnostics Group PLC
Final Results for the Year Ended 31 March 2020
link

Contacts

from Omega Diagnostics Group PLC
Walbrook PR
Financial PR and IR
atOmega Diagnostics Group PLC
020 7933 8780
omega@walbrookpr.com
Issuer presentations live and on demand
Watch on Spark Live